Author Login

Correspondence to Author: Bonucci M 

Department of Integrative Oncology, Nuova Villa Claudia Hospital, Italy.

ABSTRACT

Cancer patients are at high risk for acquiring PostTraumatic Stress Disorder (PTSD), but few research have evaluated the effectiveness of psychological therapies to treat it. Furthermore, it is understood that the presence of Unprocessed trauma prior to diagnosis increases the likelihood of developing PTSD. No research have examined the quality of traumatic experiences in C sufferers’ lives. The study aims to evaluate the effectiveness of Eye Movement Desensitization and Reprocessing therapy (EMDR) in PTSD patients, identify unprocessed traumatic experiences in their pre-diagnosis lives, and analyze these clinical experiences in relation to the primary cancer’s localization. Patients with C diagnosis at any stage.Patients with C diagnosis at any stage of the disease were enrolled and received either EMDR. Clinical questionnaires were used to examine patients before and after therapy (follow-up). Patients initially diagnosed receive 10 sessions of psychotherapy, whereas those with recurrence receive 16 sessions. We had three patients: two in the second stage of disease (just before starting medication) and one in his third recurrence. Primary cancer is typically seen in the shoulder, breast, or skin.All patients experienced complete PTSD remission, however some still had unresolved traumatic events from their pre-diagnosis life (mourning). Confirming the efficacy of EMDR in PTSD. Using a powerful psychological tool in C patients is crucial for their mental well-being and quality of life during recovery. The study examines the correlation between raw traumatic episodes previous to PTSD diagnosis and onset, as well as their character. Clinical data is crucial for planning quality and time-sensitive therapies, as well as developing personalized psychological preventative strategies for individuals.

Citation:

Bonucci M. Eye Movement Desensitization and Reprocessing Treatment for Oncological Patients. Preliminary Research Project. The European Journal of Cancer 2024.